Synthesis of selective BCL-XL PROTAC and potent antitumor activity in glioblastoma
1p19q co-deletion is an independent prognostic factor in glioma with TERT promoter mutations
MYC-Mediated Inhibition of ARNT2 Uncovers a Key Tumor Suppressor in Glioblastoma
Epigenetic reactivation of a neurodevelopmental phosphoprotein program in pituitary adenomas
Transgenic T cell therapy targeting the glioblastoma stem cell antigen PTPRZ1 with a vaccine-induced, patient-derived T cell receptor
Local Drug Delivery using Novel Hydrogel Achieves 10 mm of Drug Penetration in the Tumor Microenvironment
γ-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent manner
High expression of LncRNA HOTAIR is a risk factor for temozolomide resistance in glioblastoma via activation of the miR-214/β-catenin/MGMT pathway
Exosome-derived circ-001422 promote tumor-associated macrophage M2 polarization to accelerate the progression of glioma
Risk factors associated with leptomeningeal metastases after postoperative stereotactic radiotherapy for brain metastases